{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:53:43Z","timestamp":1770720823061,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Haemophilia A (HA) is an X\u2010linked recessive bleeding disorder caused by mutations in the factor VIII gene (<jats:italic>F8<\/jats:italic>), which encodes factor VIII (FVIII) protein, a plasma glycoprotein, that plays an important role in the blood coagulation cascade. In the present study, our aim was to identify <jats:italic>F8<\/jats:italic> gene mutations in HA patients from Jordan. One hundred and seventy\u2010five HA patients from 42 unrelated families were included in this study. Among these patients, 117 (67%) had severe HA, 13 (7%) had moderate HA and 45 (26%) had mild HA. Severe patients were first tested for intron\u201022 inversion using long range polymerase chain reaction (PCR), then negative patients were tested for intron\u20101 inversion using PCR. Sequencing for the entire F8 gene was performed for all severe HA patients who were found negative for intron\u201022 and \u20101 inversions and it was also performed for moderate and mild HA patients. HA causative mutations were identified in all patients. Intron\u201022 and \u20101 inversions were detected in 52% and 2% of families respectively. Beside these two mutations, 19 different mutations were identified, which include 15 missense and four frameshift mutations. Five novel mutations were identified including one frameshift and four missense mutations. No large deletions or nonsense mutations were detected in patients who participated in this study. Only 17 patients with severe HA were found positive for FVIII inhibitors. The data presented will play an important role for genetic counselling and health care of HA patients in Jordan.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2009.02081.x","type":"journal-article","created":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T01:28:10Z","timestamp":1254965290000},"page":"136-142","source":"Crossref","is-referenced-by-count":13,"title":["Study of mutations in Jordanian patients with haemophilia A: identification of five novel mutations"],"prefix":"10.1111","volume":"16","author":[{"given":"A.","family":"AWIDI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"RAMAHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"AlHATTAB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"MEFLEH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"DWEIRI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"BSOUL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"MAGABLAH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"ARAFAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"BARQAWI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"BISHTAWI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"HADDADEEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"FALAH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"TARAWNEH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"SWAIDAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"FAUORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,29]]},"reference":[{"key":"e_1_2_8_2_2","article-title":"Definitions in hemophilia: recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis [letter]","volume":"85","author":"White GC","year":"2001","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_3_2","unstructured":"HAMSTeRs.The Haemophilia A mutation structure test and resource site http:\/\/europium.csc.mrc.ac.uk(last accessed on 2 September 2009)."},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/312326a0"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1193-236"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.168"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10056"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000093559"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1661094"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.4.1458"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-026104"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.6.2206.bloodjournal8662206"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07310.x"},{"key":"e_1_2_8_14_2","first-page":"7","article-title":"Risk factors for inhibitor development in haemophilia A","volume":"85","author":"Oldenburg J","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.0562i.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3282f9b193"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/46601"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2413"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1234"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20208"},{"key":"e_1_2_8_21_2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1055\/s-0037-1613931","article-title":"Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate\u2122)","volume":"83","author":"Goodeve A","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_22_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00001721-199310000-00012","article-title":"Incidence of inhibitors in haemophiliacs. A review of the literature","volume":"4","author":"Scharrer I","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-37936"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-8216.2001.00134.x"},{"key":"e_1_2_8_25_2","first-page":"11402","article-title":"Haemophilia A mutation type determines risk of inhibitor formation","volume":"74","author":"Schwaab R","year":"1995","journal-title":"Thromb Haemost"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2009.02081.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2009.02081.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T03:53:18Z","timestamp":1698637998000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2009.02081.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1365-2516.2009.02081.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02081.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,29]]}}}